Cargando…

Obinutuzumab activates FcγRI more potently than other anti-CD20 antibodies in chronic lymphocytic leukemia (CLL)

Treatment with monoclonal antibodies has revolutionized clinical medicine, especially in the fields of cancer and immunology. One of the oldest antibodies, which is widely used for the treatment of lymphomas and autoimmune diseases, is the anti-CD20 antibody rituximab. In recent years, new antibodie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elias, Shlomo, Kahlon, Shira, Kotzur, Rebecca, Kaynan, Noah, Mandelboim, Ofer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980409/ https://www.ncbi.nlm.nih.gov/pubmed/29872553 http://dx.doi.org/10.1080/2162402X.2018.1428158

Ejemplares similares

Eradication of CD48-positive tumors by selectively enhanced YTS cells harnessing the lncRNA NeST
por: Kotzur, Rebecca, et al.
Publicado: (2023)

Use of obinutuzumab for refractory autoimmune thrombocytopenia secondary to CLL
por: Agrawal, Rohitashva, et al.
Publicado: (2020)

The Importance of Human FcγRI in Mediating Protection to Malaria
por: McIntosh, Richard S, et al.
Publicado: (2007)

Obinutuzumab in Allogeneic Transplantation for CLL and Richter’s Transformation in the Age of Targeted Therapies
por: Pflug, Natali, et al.
Publicado: (2021)

Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL
por: Mascolo, Annamaria, et al.
Publicado: (2023)

Universal Antibody Conjugation to Nanoparticles Using the Fcγ Receptor I (FcγRI): Quantitative Profiling Of Membrane Biomarkers
por: Kim, Chloe, et al.
Publicado: (2014)

Population Pharmacokinetics of Obinutuzumab (GA101) in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma and Exposure–Response in CLL
por: Gibiansky, E, et al.
Publicado: (2014)

Anti-RhD antibody therapy modulates human natural killer cell function
por: Elias, Shlomo, et al.
Publicado: (2020)

Obinutuzumab-mediated high-affinity ligation of FcγRIIIA/CD16 primes NK cells for IFNγ production
por: Capuano, Cristina, et al.
Publicado: (2017)

Targeting the high affinity receptor, FcγRI, in autoimmune disease, neuropathy, and cancer
por: Holtrop, Tosca, et al.
Publicado: (2022)

Immunoglobulin G inhibits glucocorticoid-induced osteoporosis through occupation of FcγRI
por: Jiang, Lijuan, et al.
Publicado: (2023)

Sequential treatment with bendamustine, obinutuzumab (GA101) and Ibrutinib in chronic lymphocytic leukemia (CLL): final results of the CLL2-BIG trial
por: von Tresckow, Julia, et al.
Publicado: (2022)

Identification of cyclic peptides able to mimic the functional epitope of IgG1-Fc for human FcγRI
por: Bonetto, Stephane, et al.
Publicado: (2009)

Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab
por: Freeman, C L, et al.
Publicado: (2016)

Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study
por: Stilgenbauer, Stephan, et al.
Publicado: (2018)

FcγRI and FcγRIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/IIIa autoantibody-opsonized platelets in immune thrombocytopenia
por: Norris, Peter A. A., et al.
Publicado: (2020)

Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia
por: Al-Sawaf, Othman, et al.
Publicado: (2023)

Immunomodulation: Immunoglobulin Preparations Suppress Hyperinflammation in a COVID-19 Model via FcγRIIA and FcαRI
por: Bohländer, Fabian, et al.
Publicado: (2021)

FcεRI γ-Chain Negatively Modulates Dectin-1 Responses in Dendritic Cells
por: Pan, Yi-Gen, et al.
Publicado: (2017)

Combinatorial diversity of Syk recruitment driven by its multivalent engagement with FcεRIγ
por: Travers, Timothy, et al.
Publicado: (2019)

Sensory Neuron Expressed FcγRI Mediates Postinflammatory Arthritis Pain in Female Mice
por: Liu, Yan, et al.
Publicado: (2022)

A Pathogenic Role for FcγRI in the Immune Response against Chlamydial Respiratory Infection
por: Zeng, Jiajia, et al.
Publicado: (2022)

The high-affinity human IgG receptor Fc gamma receptor I (FcγRI) is not associated with vascular leakage of dengue
por: Mohamad Zamberi, Zaiharina, et al.
Publicado: (2015)

FcγRI expression on macrophages is required for antibody-mediated tumor protection by cytomegalovirus-based vaccines
por: Benonisson, Hreinn, et al.
Publicado: (2018)

Lenalidomide and Pomalidomide Improve Function and Induce FcγRI/CD64 in Multiple Myeloma Neutrophils
por: Romano, Alessandra, et al.
Publicado: (2021)

Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia
por: Al-Sawaf, Othman, et al.
Publicado: (2023)

An Interaction Library for the FcεRI Signaling Network
por: Chylek, Lily A., et al.
Publicado: (2014)

The Viral KSHV Chemokine vMIP-II Inhibits the Migration of Naive and Activated Human NK Cells by Antagonizing Two Distinct Chemokine Receptors
por: Yamin, Rachel, et al.
Publicado: (2013)

Increased expression of FcγRI/CD64 on circulating monocytes parallels ongoing inflammation and nephritis in lupus
por: Li, Yi, et al.
Publicado: (2009)

Structural insights into the interaction of human IgG1 with FcγRI: no direct role of glycans in binding
por: Oganesyan, Vaheh, et al.
Publicado: (2015)

Membrane nanoclusters of FcγRI segregate from inhibitory SIRPα upon activation of human macrophages
por: Lopes, Filipa B., et al.
Publicado: (2017)

The Influence of Glycans-Specific Bioconjugation on the FcγRI Binding and In vivo Performance of (89)Zr-DFO-Pertuzumab
por: Vivier, Delphine, et al.
Publicado: (2020)

The beta subunit of the Fc epsilon RI is associated with the Fc gamma RIII on mast cells
Publicado: (1992)

NK Cells Under Hypoxia: The Two Faces of Vascularization in Tumor and Pregnancy
por: Garcés-Lázaro, Irene, et al.
Publicado: (2022)

Immunoglobulin-binding Sites of Human FcαRI (CD89) and Bovine Fcγ2R Are Located in their Membrane-distal Extracellular Domains
por: Craig Morton, H., et al.
Publicado: (1999)

Coaggregation of FcεRI with FcγRIIB Inhibits Degranulation but Not Induction of Bcl-2 Family Members A1 and Bim in Mast Cells
por: Ekoff, Maria, et al.
Publicado: (2006)

Hypersensitivity reactions to asparaginase in mice are mediated by anti-asparaginase IgE and IgG and the immunoglobulin receptors FcεRI and FcγRIII
por: Rathod, Sanjay, et al.
Publicado: (2019)

IgG-Independent Co-aggregation of FcεRI and FcγRIIB Results in LYN- and SHIP1-Dependent Tyrosine Phosphorylation of FcγRIIB in Murine Bone Marrow-Derived Mast Cells
por: Gast, Mathias, et al.
Publicado: (2018)

S145: VENETOCLAX-OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: 6-YEAR RESULTS OF THE RANDOMIZED CLL14 STUDY
por: Al-Sawaf, Othman, et al.
Publicado: (2023)

Altered expression of the TCR signaling related genes CD3 and FcεRIγ in patients with aplastic anemia
por: Li, Bo, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_03pau0gqklu0qms355ands8qgc